title: Overview of Glucagon-like Peptide-1 Receptor Agonists.
abstract: Type 2 diabetes mellitus is an increasingly prevalent disease in the United States and globally. Multiple pharmacologic therapies are typically required over time to achieve and maintain target blood glucose levels. When first-line oral medications such as metformin (Glucophage) are not effective in achieving desired glycosylated hemoglobin (HbA1C) levels, glucagon-like peptide-1 receptor agonists may be used. This article provides an overview of this class of agents and provides implications for home healthcare clinicians.
authors.affiliation: Laura Steadman, EdD, CRNP, is an Assistant Professor, School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama. Joan S. Grant, PhD, RN, is a Professor, School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama. Lucinda J. Graven, PhD, MSN, ARNP, is an Assistant Professor, College of Nursing, Florida State University, Tallahassee, Florida.
authors.forename: Laura
authors.initials: L
authors.lastname: Steadman
authors.forename: Joan S
authors.initials: JS
authors.lastname: Grant
authors.forename: Lucinda J
authors.initials: LJ
authors.lastname: Graven
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000067757:Glucagon-Like Peptide-1 Receptor / Q000037:antagonists & inhibitors*; D006699:Home Care Services; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*
chemical_list: D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents